CME Group to Launch T-Bill Futures on October 2, as U.S. Treasury Futures Open Interest Hits Record 19.8 Million Contracts
- Expansion of benchmark interest rates offering with T-Bill futures
- Record demand and open interest in U.S. Treasury futures
- None.
"As we continue to see record risk transfer in the
Adding to the CME Group short-term interest rate (STIR) product portfolio, T-Bill futures will be cash-settled and based on the 13-week
T-Bill futures will receive automatic margin offsets against existing CME Group Interest Rate futures upon launch and will be listed with, and subject to, the rules of CME. Additionally, these contracts will become eligible for portfolio margining against other cleared interest rate swaps and futures shortly after launch.
Open interest in the company's current suite of deeply liquid
For more information on T-Bill futures from CME Group, please see: https://www.cmegroup.com/tbill.
About CME Group
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and
CME-G
View original content:https://www.prnewswire.com/news-releases/cme-group-to-launch-t-bill-futures-on-october-2--as-us-treasury-futures-open-interest-hits-record-19-8-million-contracts-301916527.html
SOURCE CME Group